The reasons for increased obesity prevalence include rising trends...
Category:
Health
Latest
Govt plans to develop 600 wayside amenities on highways including clinics
"The amenities will include numerous facilities for passengers such...
Mukesh Ambani to foray into genome testing with a $145 kit
The genome test, which is about 86% cheaper than other offerings...
Headwinds for Google as rivals, customers criticise Fitbit concessions
Alphabet’s Google last week offered to restrict the use of Fitbit data for Google ads and to monitor the process closely.
It also offered to make it easier for rival makers of wearables to connect to the Android platform by offering them access to Android software (API), and said third parties would continue to have access to Fitbit users’ data with their consent.
Oxford University Covid-19 vaccine could be rolled out within 6 months: Report
Under a protocol developed by the UK’s Joint Committee on Vaccination and Immunisation, any approved vaccine will then be given to all over 65s, followed by younger adults at higher risk, which could include those from ethnic minorities as well as those with serious health issues based on their higher risk from the deadly virus. People over 50 will be next in line, with younger adults at the back of the queue.
Pandemics overtakes climate change as biggest worry for insurers
COVID-19 is proving to be a major challenge for insurers, especially those that provide cover for canceled events such as sports matches and concerts. Disputes over coverage have led some policyholders to take legal action, with AXA recently losing a lawsuit against five restaurant operators. The insurer said it will appeal the ruling.
COVID-19 vaccine rollout unlikely before fall 2021, experts say
“Experts in our survey offered forecasts on vaccine development that were generally less optimistic than the timeline of early 2021 offered by US public officials,” Jonathan Kimmelman, a professor at McGill University, said in a statement.
“In general they seem to believe that a publicly available vaccine next summer is the best-case scenario with the possibility that it may take until 2022,” said Kimmelman, the senior author on the paper published in the Journal of General Internal Medicine.
Scientists identify unique patterns in COVID-19 transmission in India
According to the scientists, including Ramanan Laxminarayan from the Center for Disease Dynamics, Economics, and Policy in New Delhi, the findings offer a peek into the pandemic’s trajectory in a low- and middle-income country, where most COVID-19 cases have occurred
New global lab network will compare COVID-19 vaccines head-to-head
Speaking to Reuters ahead of announcing the labs involved, Melanie Saville, director of vaccine R&D at the Coalition for Epidemic Preparedness Innovations (CEPI), said the idea was to “compare apples with apples” as drugmakers race to develop an effective shot to help control the COVID-19 pandemic.
The faces of India’s coronavirus pandemic as deaths hit 100,000
In what is still a conservative and developing country, some of the relatives said they faced ostracism after their loved ones caught the virus. Others said they have suffered from depression and money troubles. All said more could have been done to save the people who died
Covid-sniffing robots offer testing alternative
“Our goal is to have a device that merges synthetic biology with silicon and maps all of the smells of human life on a global scale,” said Oshiorenoya Agabi, the San Rafael, California-based company’s chief executive officer and co-founder. “We should have a device in every home in America to screen for disease.”
Second sero survey indicates reduction in infections in Mumbai slums
Mumbai is one of the worst-affected COVID-19 hotspots in the country with over two lakh cases and nearly 9,000 deaths so far.
Push to bring coronavirus vaccines to the poor faces trouble
In one of the biggest obstacles, rich countries have locked up most of the world’s potential vaccine supply through 2021, and the U.S. and others have refused to join the project, called Covax.
The supply of vaccines is not going to be there in the near term, and the money also isn’t there, warned Rohit Malpani, a public health consultant who previously worked for Doctors Without Borders.